Chemical Structure : GPR30 agonist G-1
CAS No.: 881639-98-1
Catalog No.: PC-60270Not For Human Use, Lab Use Only.
GPER/GPR30 agonist G-1 (Tespria) is potent and selective GPER/GPR30 agonist with Ki of 11 nM, EC50 of 2 nM.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $88 | In stock | |
10 mg | $128 | In stock | |
25 mg | $218 | In stock | |
50 mg | $368 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
GPER/GPR30 agonist G-1 (Tespria) is potent and selective GPER/GPR30 agonist with Ki of 11 nM, EC50 of 2 nM.
GPER/GPR30 agonist G-1 displays no activity at ERα and ERβ at concentrations up to 10 uM.
GPER/GPR30 agonist G-1 increases cytosolic Ca2+ and inhibits migration of SKBr3 cells and MCF-7 cells in response to chemoattractants with IC50 of 0.7 and 1.6 nM respectively.
GPER/GPR30 agonist G-1 induces cell cycle arrest, DNA damage and cell death by the activation of the intrinsic apoptotic mechanism in H295R cells.
M.Wt | 412.28 | |
Formula | C21H18BrNO3 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(±)-1-[(3aR*,4S*,9bS*)-4-(6-Bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]- ethanone |
1. Wang C, et al. Mol Endocrinol. 2008 Mar;22(3):636-48.
2. Chimento A, et al. Oncotarget. 2015 Aug 7;6(22):19190-203.
3. Ahola TM, et al. Endocrinology. 2002 Sep;143(9):3376-84.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright